Live
Home·Deals·HealthTech·HRS acquires Rimidi
SEO URLwww.firestrike.ai/deals/rimidi-hrs-acquisition-2026
acquisitionAnnounced · Mar 20, 2026HealthTechSource · Community DiscussionsArticle · Factual
Rimidi
HRS
Rimidi · HRS

HRS acquires Rimidi

David Najork
David Najork · Founding Software Engineer
Published · Updated · 2 min read
ShareXLinkedInEmail
Deal value
Target
Rimidi
Rimidi
Atlanta, Georgia
Acquirer
HRS
HRS
Full Acquisition
Status
Completed

Health Recovery Solutions (HRS), a prominent player in remote patient monitoring and enterprise remote care, has announced the acquisition of Rimidi. The purchase, for an undisclosed sum, aims to bolster HRS's capabilities in virtual care by integrating Rimidi's expertise in chronic disease management, particularly in diabetes and cardiometabolic care.

The acquisition aligns with HRS’s strategic push to enhance its virtual care platform, which includes expanding electronic health record (EHR) and workflow integrations, as well as continuous glucose monitoring and ambulatory care. Rimidi, known for its pioneering work in chronic disease management, offers advanced clinical decision support in ambulatory settings, facilitating scalable and efficient care. This acquisition is designed to enhance HRS’s ability to provide comprehensive, connected care across a patient’s journey.

For HRS, the acquisition of Rimidi complements its recent developments such as the PatientFirst Pathways initiative launched in 2025, which expanded the delivery of longitudinal care at home. These strategic moves have positioned HRS as a full-service chronic care management provider, and the integration of Rimidi’s technology and expertise is expected to streamline and scale their virtual care programs, addressing the need for comprehensive solutions in chronic disease management.

This acquisition also underscores the growing demand for platforms capable of managing multiple chronic conditions efficiently. Health systems increasingly require scalable solutions that offer integration across various conditions, an area where Rimidi has built a strong reputation. Bringing together HRS’s post-acute expertise with Rimidi’s capabilities in cardiometabolic and diabetes management highlights a strategic bid to reinforce their leadership in remote patient monitoring.

Looking ahead, the integration of Rimidi’s services and technology into HRS’s existing platform will be crucial. The landscape for health technology continues to evolve, with pressure mounting on companies to deliver more integrated, efficient, and scalable remote care solutions. Both companies' established positions in the industry presumably make the transition smoother, though successfully merging their operations will be key in capitalizing on this acquisition. The future will likely involve a focus on ensuring seamless interoperability and maintaining high standards of patient care amidst increasing market competition.

Deal timeline

Announced
Mar 20, 2026 · healthcareittoday.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in HealthTech. Figures and status may change as sources update.

Sources: healthcareittoday.com · Primary article · FireStrike proprietary index